Cashman NR - Search Results

1

Update on the provisional estimation of developing iatrogenic variant Creutzfeldt-Jakob disease from human islet cell transplantation procedures.

Tyshenko MG, Bertram L, Li L, ElSaadany S, Samis J, Krewski D, Cashman NR. Tyshenko MG, et al. Among authors: cashman nr. Transplantation. 2014 Jun 27;97(12):e73-5. doi: 10.1097/TP.0000000000000176. Transplantation. 2014. PMID: 24933255 No abstract available.

2

Is Creutzfeldt-Jakob disease transmitted in blood?

Ricketts MN, Cashman NR, Stratton EE, ElSaadany S. Ricketts MN, et al. Among authors: cashman nr. Emerg Infect Dis. 1997 Apr-Jun;3(2):155-63. doi: 10.3201/eid0302.970208. Emerg Infect Dis. 1997. PMID: 9204296 Free PMC article. Review.

3

Species barriers for chronic wasting disease by in vitro conversion of prion protein.

Li L, Coulthart MB, Balachandran A, Chakrabartty A, Cashman NR. Li L, et al. Among authors: cashman nr. Biochem Biophys Res Commun. 2007 Dec 28;364(4):796-800. doi: 10.1016/j.bbrc.2007.10.087. Epub 2007 Oct 25. Biochem Biophys Res Commun. 2007. PMID: 17964288

4

Immunological mimicry of PrPC-PrPSc interactions: antibody-induced PrP misfolding.

Li L, Guest W, Huang A, Plotkin SS, Cashman NR. Li L, et al. Among authors: cashman nr. Protein Eng Des Sel. 2009 Aug;22(8):523-9. doi: 10.1093/protein/gzp038. Epub 2009 Jul 14. Protein Eng Des Sel. 2009. PMID: 19602568

5

Prion research in perspective. Preface.

Cashman N, Darshan S, Krewski D, Tyshenko MG. Cashman N, et al. J Toxicol Environ Health A. 2009;72(17-18):999. doi: 10.1080/15287390903084041. J Toxicol Environ Health A. 2009. PMID: 19697231 No abstract available.

6

Prionet Canada: a network of centres of excellence for research into prions and prion diseases.

Wong M, Toth J, Haney S, Tyshenko MG, Darshan S, Krewski D, Leighton FA, Westaway D, Moore SS, Ricketts M, Cashman N. Wong M, et al. J Toxicol Environ Health A. 2009;72(17-18):1000-7. doi: 10.1080/15287390903084108. J Toxicol Environ Health A. 2009. PMID: 19697232

7

Immunotherapy for prion diseases: opportunities and obstacles.

Li L, Napper S, Cashman NR. Li L, et al. Among authors: cashman nr. Immunotherapy. 2010 Mar;2(2):269-82. doi: 10.2217/imt.10.3. Immunotherapy. 2010. PMID: 20635933 Review.

8

Preface. Prion research in perspective.

Cashman NR, Darshan S, Krewski D, Tyshenko MG. Cashman NR, et al. J Toxicol Environ Health A. 2011;74(2-4):71-2. doi: 10.1080/15287394.2011.544239. J Toxicol Environ Health A. 2011. PMID: 21218335 No abstract available.

9

PrioNet Canada: a network of centres of excellence for research on prion diseases--ongoing and future research directions.

Wong M, Toth J, Haney S, Krewski D, Leighton FA, Ricketts M, Westaway D, Cashman N. Wong M, et al. J Toxicol Environ Health A. 2011;74(2-4):73-87. doi: 10.1080/15287394.2011.529056. J Toxicol Environ Health A. 2011. PMID: 21218336

10

Preface. Prion research in perspective III.

Cashman N, Darshan S, Krewski D, Tyshenko MG. Cashman N, et al. J Toxicol Environ Health A. 2011;74(22-24):1431-2. doi: 10.1080/15287394.2011.618966. J Toxicol Environ Health A. 2011. PMID: 22043905 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page